During the past decade, Berkshire Medical Center - Cancer Center conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 13 clinical trials were completed, i.e. on average, 86.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 11 clinical trials were completed. i.e. 550% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berkshire Medical Center - Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 18 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "AB Science" with 1 trials sponsored, "Agennix" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berkshire Medical Center - Cancer Center" #1 collaborator was "NRG Oncology" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Berkshire Medical Center - Cancer Center" are "Breast Adenocarcinoma" (4 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (4 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (4 trials), "Stage IB Breast Cancer AJCC v7" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Berkshire Medical Center - Cancer Center" in a lesser frequency.

Most popular intervention types in "Berkshire Medical Center - Cancer Center" are "Drug" (25 trials), "Other" (23 trials), "Biological" (12 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Quality-of-Life Assessment" (12 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Berkshire Medical Center - Cancer Center" are 22 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Berkshire Medical Center - Cancer Center". undefined are not yet recruiting, 5 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Berkshire Medical Center - Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Berkshire Medical Center - Cancer Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".